Scientists at Oxford University are rapidly developing a new experimental vaccine against the rare Bundibugyo Ebola variant, potentially ready for clinical trials in 2-3 months. The current outbreak in the Democratic Republic of Congo has seen 750 suspected cases and 177 deaths.
A Bundibugyo Ebola variant outbreak in the DRC and Uganda is exacerbated by massive US cuts to global health funding and staff, leaving health leaders scrambling to contain the spread. Experts criticize the US withdrawal as a self-inflicted wound, hindering early detection and response efforts.
As a new Ebola outbreak spreads rapidly in the DRC, lessons from the 2018-2020 crisis in Butembo highlight challenges like insecurity, community mistrust, and the exploitation of the outbreak for political gain. The WHO's quicker declaration of a public health emergency this time reflects lessons learned, though the current Bundibugyo variant lacks specific vaccines.
